XML 51 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Loss Before Income Taxes

Income Before Taxes

The domestic and foreign components of loss before income taxes were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

United States

 

$

(44,321

)

 

$

(28,803

)

Foreign

 

 

142

 

 

 

87

 

 

 

$

(44,179

)

 

$

(28,716

)

Reconciliation of U.S. Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Federal statutory income tax rate

 

 

(21.0

)%

 

 

(21.0

)%

State taxes, net of federal benefit

 

 

(6.9

)%

 

 

(5.7

)%

Federal and state research and development tax

   credits

 

 

(2.4

)%

 

 

(3.6

)%

Nondeductible items

 

 

(3.2

)%

 

 

(0.2

)%

Deferred tax effect of change in state blended rate

 

 

(1.7

)%

 

 

7.8

%

Return to provision

 

 

1.1

%

 

 

1.7

%

Other

 

 

(0.2

)%

 

 

0.0

%

Change in deferred tax asset valuation allowance

 

 

34.3

%

 

 

20.9

%

Effective income tax rate

 

 

0.0

%

 

 

(0.1

)%

Schedule of Net deferred Tax Assets

Net deferred tax assets consisted of the following (in thousands):

 

 

 

December 31,

 

 

 

2021

 

 

2020

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

94,672

 

 

$

81,390

 

Capitalized research and development expense

 

 

4,291

 

 

 

6,136

 

Research and development tax credit carryforwards

 

 

12,186

 

 

 

11,541

 

Accrued expenses

 

 

2,528

 

 

 

1,390

 

Stock-based compensation expense

 

 

2,254

 

 

 

791

 

Deferred rent

 

 

 

 

 

79

 

Lease liability

 

 

2,299

 

 

 

 

Other

 

 

170

 

 

 

132

 

Total deferred tax assets

 

 

118,400

 

 

 

101,459

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Other

 

 

(674

)

 

 

(218

)

Right-of-use assets

 

 

(1,562

)

 

 

 

Unrealized gain (loss)

 

 

 

 

 

(212

)

Total deferred tax liabilities

 

 

(2,236

)

 

 

(430

)

Valuation allowance

 

 

(116,164

)

 

 

(101,029

)

Net deferred tax assets

 

$

 

 

$

 

Summary Changes in the Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2021 and 2020 related primarily to the increase in net operating loss carryforwards and research and development tax credit carryforwards in 2021 and 2020, and were as follows (in thousands):

 

 

 

Year Ended December 31,

 

 

 

2021

 

 

2020

 

Valuation allowance as of beginning of year

 

$

(101,029

)

 

$

(95,024

)

Decreases recorded as benefit to income tax provision

 

 

 

 

 

 

Increases recorded to income tax provision

 

 

(15,135

)

 

 

(6,005

)

Valuation allowance as of end of year

 

$

(116,164

)

 

$

(101,029

)